1642. [Prognostic factors of advanced stage non-small-cell lung cancer].
作者: H Kwas.;E Guermazi.;A Khattab.;C Hrizi.;I Zendah.;H Ghédira.
来源: Rev Pneumol Clin. 2017年73卷4期180-187页
Primary lung cancer is the leading cause of cancer death in men in the world. Although the introduction of new drugs, new therapeutic strategies and despite therapeutic advances, the prognosis is relatively improved during the last years.
1643. [Malignant proliferating trichilemmal cyst of the scalp: A case report].
作者: J ElBenaye.;Y Elkhachine.;A Sakkah.;M Sinaa.;M Moumine.;A Jakar.;M Elhaouri.
来源: Ann Chir Plast Esthet. 2018年63卷1期97-101页
Proliferating trichilemmal cyst (PTC) is a rare adnexal tumor, generally benign, primarily sitting on the scalp of elderly women. About fifty cases are reported in the literature. Herein, we describe another one particularly aggressive.
1644. [Dermatofibrosarcoma protuberans: Surgical margins using Slow-Mohs micrographic surgery. A clinical retrospective study about 20 cases].
作者: C Verbruggen.;A S Ricard.;O Cogrel.;M Bondaz.;S Carrier.
来源: Ann Chir Plast Esthet. 2018年63卷1期47-53页
The main objective of this study is to determine the necessary surgical margins to obtain a complete R0 resection for head and neck dermatofibrosarcoma protuberans (DFSP) using Slow-Mohs micrographic surgery. The secondary objective is to study the recurrence rate of these tumors.
1649. [Care pathway of patients with hepatocellular carcinoma in France: State of play in 2017].
作者: Charlotte Costentin.;Nathalie Ganne-Carrié.;Benoit Rousseau.;René Gérolami.;Jean-Claude Barbare.
来源: Bull Cancer. 2017年104卷9期752-761页
Hepatocellular carcinoma is a major public health problem with one of the highest overall mortality compared to other cancers. The median overall survival in France in a hospital population with hepatocellular carcinoma is 9.4 months. Several publications reported a positive impact of hepatocellular carcinoma screening on diagnosis at an early-stage, eligibility for curative treatment and overall survival. However, the identification of patients to be included in a hepatocellular carcinoma screening program and the application of screening recommendations are not optimal. Other studies suggest a potentially negative impact of delayed diagnosis or treatment initiation on the patient's prognosis. Finally, marked variations between French regions and departments have been described in terms of access to curative treatment and overall survival. In this review article, we propose a state of play of the hepatocellular carcinoma patient's care pathway in France with the aim of identifying potential breaking points with negative impact on prognosis and of developing proposals for improvement.
1650. [Desquamative erythrodermia].
作者: Majda Askour.;Christelle Ebongo.;Hafsae Bounniyt.;Karima Senouci.;Badredine Hassam.
来源: Pan Afr Med J. 2017年27卷18页
Paraneoplastic dermatoses are a spectrum of cutaneous manifestations which may precede, coincide with or follow the diagnosis of cancer. Our study aims to remind clinicians that desquamative erythrodermia is a form of paraneoplastic dermatosis which may occur during hematologic malignancies. Hence the importance of a complete assessment to identify a neoplastic process in the presence of these clinical signs and especially when they are suspect.
1651. [Tubulocystic renal cell carcinoma with poorly differentiated foci].
Tubulocystic renal cell carcinoma is a rare tumor with an indolent behavior in the majority of cases. In contrast, tubulocystic renal cell carcinoma with poorly differentiated foci has a bad prognosis with an aggressive and metastatic behavior. We present the case of a patient diagnosed with tubulocystic renal cell carcinoma with poorly differentiated foci.
1652. [Multiple granular cell tumours in a patient with Noonan's syndrome and juvenile myelomonocytic leukaemia].
Granular cell tumour (GCT) is a rare form of tumour comprising Schwann cells. Herein, we report a case of a child presenting Noonan syndrome complicated by juvenile myelomonocytic leukaemia (JMML) and who also developed a multiple form of GCT. We discussed the molecular mechanisms that might account for this association.
1653. [Self-evaluation of conization indications since the introduction of the French colposcopy and cervico-vaginal pathology quality charter in 2 colposcopy centers].
作者: M Lallemant.;C Baeza.;C Monnin.;M Malincenco.;C Gay.
来源: Gynecol Obstet Fertil Senol. 2017年45卷7-8期421-428页
Analyze the efficiency of the implementation of the colposcopy and cervico-vaginal pathology quality charter. The question was to determine whether the criteria of more than 70% of excisional conizations containing CIN2+ lesions (cervical intraepithelial neoplasia 2 or 3 or carcinoma in situ) had been reached and demonstrate a reduction of the conization rate is possible.
1656. [Current knowledge on perioperative treatments of non-small cell lung carcinomas].
作者: S Brosseau.;C Naltet.;M Nguenang.;V Gounant.;P Mordant.;B Milleron.;Y Castier.;G Zalcman.
来源: Rev Mal Respir. 2017年34卷6期618-634页
Surgery is still the main treatment in early-stage of non-small cell lung cancer with 5-year survival of stage IA patients exceeding 80%, but 5-year survival of stage II patients rapidly decreasing with tumor size, N status, and visceral pleura invasion. The major metastatic risk in such patients has supported clinical research assessing systemic or loco-regional perioperative treatments. Modern phase 3 trials clearly validated adjuvant or neo-adjuvant platinum-based chemotherapy in resected stage I-III patients as a standard treatment of which value has been reassessed several independent meta-analyses, showing a 5% benefit in 5y-survival, and a decrease of the relative risk for death around from 12 to 25%. Conversely perioperative treatments were not validated for stage IA and IB patients. In more advanced stage patients, neo-adjuvant radio-chemotherapy has not been validated either. Adjuvant radiotherapy for N2 patients is currently tested in the large international phase 3 trial Lung-ART/IFCT-0503. The development of video-assisted thoracic surgery (VATS) has helped adjuvant chemotherapies for elderly patients. Perioperative targeted treatments in NSCLC with EGFR or ALK molecular alterations is currently assessed in the U.S. ALCHEMIST prospective trial. Finally, the role of immune check-points inhibitors is currently evaluated in a large international phase 3 trial testing adjuvant anti-PD-L1 monoclonal antibody, the BR31/IFCT-1401 trial, while a proof-of principle neo-adjuvant trial IONESCO/IFCT-1601, has just begun by the end of the 2016 year, with survival results of both trials expected in 5 to 7 years.
1657. [Surgical management of the spinal metastases].
作者: Dennis E Dominguez.;Nicolas Lauper.;Alejandro Velastegui.;Jermy Reynolds.
来源: Rev Med Suisse. 2016年12卷543期2168-2171页
Seventy per cent of patients with cancer have evidence of metastases and spinal involvement may occur in up to 50 %. Pain is the most frequent symptom and it occurs in 90 % of the patients. It exist three different type of spinal pain : inflammatory, radicular and mechanical pain. Pain could be related to a neurological compromise and treatment becomes urgent. Steroids are introduced even if surgery is indicated. The Spinal Instability Neoplastic Score is a useful tool in order to determine instability in spinal metastases. Early recognition of instability could allow to minimal invasive surgery and even vertebroplasty. Tokuhashi score facilitates patient's selection during the decision-making process to the multidisciplinary team.
1658. [Subsolid pulmonary nodules].
作者: Damien Keller.;Catherine Beigelman-Aubry.;Igor Letovanec.;Hasna Bouchaab.;Michel Gonzalez.;Alban Lovis.;Laurent P Nicod.;Romain Lazor.
来源: Rev Med Suisse. 2016年12卷539期1976-1982页
Subsolid nodules represent almost 20% of all pulmonary nodules found incidentally at chest computed tomography (CT). Their detection is steadily rising, in parallel with the increasing number of CT scans performed. Subsolid nodules differ from solid lung nodules in several ways: morphology, course of progression, risk of malignancy and prognosis. Although they remain a diagnostic challenge, a good correlation has been established between radiological appearance and histopathology. Whilst 75% of persistent subsolid nodules represent a form of adenocarcinoma, their prognosis is generally excellent when resected. Non-resected subsolid nodules require a long follow-up of 3 to 5 years due to their slow-growing nature and high prevalence of malignancy. Specific guidelines have been published in 2013 and in 2015.
1660. [Pancreatic-pleural fistula in children: a rare cause of great abundant pleurisy].
作者: Aida Daib.;Youssef Hellal.;Malek Boughdir.;Rabiaa Ben Abdallah.;Nejib Kaabar.
来源: Pan Afr Med J. 2017年26卷240页
Pancreatic-pleural fistula is a very rare complication of false cysts of the pancreas. Our study aimed to describe this rare pathology affecting children. We emphasized the importance of evoking this diagnosis in the presence of great abundant pleurisy even in the absence of the digestive signs. We here report the case of a 2-year old child with false cyst of the pancreas complicated by pleural fistula detected after great abundant pleurisy with no digestive signs associated.
|